Article
Is there a predictive significance of ABO blood group on chemotherapy-induced thrombocytopenia in patients with stage III colon cancer?
Medical oncology (Northwood, London, England) - 1 Jan 2015
Tanriverdi Ozgur
Abstract excerpt
Chemotherapy-induced thrombocytopenia (CIT) is the most important cause of thrombocytopenia in cancer patients. In this paper, I discussed the effect of ABO blood group on CIT in patients with stage III colon cancer. In a pilot study, a total of 131 (72 men, 55 %) eligible patients with stage III colon cancer were divided into two groups according to whether they had CIT. Both groups were compared using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
